Status:
COMPLETED
Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome
Lead Sponsor:
Jewish General Hospital
Collaborating Sponsors:
Providence Healthcare
Mount Sinai Hospital, Canada
Conditions:
Patient Empowerment
Low Anterior Resection Syndrome
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
After surgery for rectal cancer, many people undergo changes in bowel habits, which may include the need to empty their bowels more often, accidental leakage of stool or gas, the sudden urge to go to ...
Detailed Description
Restorative proctectomy is increasingly being performed for rectal cancer, allowing patients to avoid permanent colostomy. Low Anterior Resection Syndrome (LARS) refers to a constellation of bowel sym...
Eligibility Criteria
Inclusion
- underwent restorative protectomy for Neo-plastic disease of the rectum
- completed all treatment within the last 3 years
- patients with minor or major LARS as defined with the LARS score.
Exclusion
- Active chemotherapy or radiotherapy
- Major colonic resection in addition to protectomy
- Cannot be contacted by telephone
- Unable to read and comprehend English/French
- Does not have the appropriate interface to access the app
- Unable to give clear and informed consent
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04469426
Start Date
August 15 2020
End Date
November 12 2024
Last Update
November 29 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
St Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
2
Mount Sinai Hospital
Toronto, Ontario, Canada
3
University Health Network
Toronto, Ontario, Canada
4
Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2